Home

Omslag 2020 06 kijk verder

Keywords register: bijwerkingen

Klinische Praktijk

2018/6

M.N. Cappai, B.A.W. Jacobs, L. Tulner, T.J. Holwerda

Hypomania induced by intranasal corticosteroid fluticasone spray, 419 - 419

Short report

2014/6

H.J. Kolthof

Modern antidepressants and hallucinations, 407 - 412

Review article

2011/1

L. Seurs, A. Mierzejewska, S.J. Claes

Corticosteroid-induced paranoid psychosis: case report and review of the literature , 37 - 47

Case report

2010/2

A.I.A. Ahmed, P.J.W.B. van Mierlo, J.A. van Waarde, P.A.F. Jansen

Hallucinations and vivid dreams by use of metoprolol , 117 - 121

Case report

2010/11

D. Cohen

Clozapine screening: white bloodcell counts no longer sufficient , 785 - 790

State-of-the-art-article

2007/10

H. Knegtering, R. Bruggeman , S. Castelein, D. Wiersma

Antipsychotics and sexual functioning in persons with psychoses , 733 - 742

Case report

2004/2

T.J. Holwerda, P.F.J. Schulte, M.G. Charbon-Rosier

Hyponatraemia: a possible side-effect of SSRI's, 115 - 119

Short report

2004/10 Themanummer Meetinstrumenten

P.N. van Harten

Instruments for measuring medication-induced movement disorders , 711 - 715

Case report

2002/1

I.M. van Vliet, A.R. van Gool

Mania associated with the use of interferon-alfa, 51 - 54

Review article

2001/2

J.M. van Bruggen, D.H. Linszen, P.M.A.J. Dingemans, B.P.R. Gersons

Weight gain and antipsychotic drugs, 95 - 104

Short report

2001/10

P.F.J. Schulte

The place of clozapine in the treatment of schizophrenia, 715 - 720

Case report

2000/2

J. Vink

Fever and leukocytosis as transient adverse effects of clozapine, 121 - 125

Short report

2000/11

A.C.M. Vergouwen, A. Bakker

Selective serotonin reuptake inhibitors and discontinuation symptoms: A literature review and its clinical relevance, 845 - 849

Short report

2000/1 Millenniumnummer

F. van Ree

Electroconvulsive therapy at the turn of the millennium, 19 - 22

State-of-the-art-article

1999/4

W.M.A. Verhoeven, S. Tuinier †

Pharmacotherapy in people with learning disabilities; a dimensional approach , 219 - 231